137 related articles for article (PubMed ID: 37075527)
1. Serum concentration of high-mobility group box 1, Toll-like receptor 4 as biomarker in epileptic patients.
Yue Z; Tang J; Peng S; Cai X; Rong X; Yang L
Epilepsy Res; 2023 May; 192():107138. PubMed ID: 37075527
[TBL] [Abstract][Full Text] [Related]
2. Circulating high mobility group box-1 and toll-like receptor 4 expressions increase the risk and severity of epilepsy.
Kan M; Song L; Zhang X; Zhang J; Fang P
Braz J Med Biol Res; 2019; 52(7):e7374. PubMed ID: 31241711
[TBL] [Abstract][Full Text] [Related]
3. High Mobility Group Box 1 is a novel pathogenic factor and a mechanistic biomarker for epilepsy.
Ravizza T; Terrone G; Salamone A; Frigerio F; Balosso S; Antoine DJ; Vezzani A
Brain Behav Immun; 2018 Aug; 72():14-21. PubMed ID: 29031614
[TBL] [Abstract][Full Text] [Related]
4. Receptor for Advanced Glycation Endproducts is upregulated in temporal lobe epilepsy and contributes to experimental seizures.
Iori V; Maroso M; Rizzi M; Iyer AM; Vertemara R; Carli M; Agresti A; Antonelli A; Bianchi ME; Aronica E; Ravizza T; Vezzani A
Neurobiol Dis; 2013 Oct; 58():102-14. PubMed ID: 23523633
[TBL] [Abstract][Full Text] [Related]
5. HMGB1 mediates microglia activation via the TLR4/NF-κB pathway in coriaria lactone induced epilepsy.
Shi Y; Zhang L; Teng J; Miao W
Mol Med Rep; 2018 Apr; 17(4):5125-5131. PubMed ID: 29393419
[TBL] [Abstract][Full Text] [Related]
6. Association analysis of high-mobility group box-1 protein 1 (HMGB1)/toll-like receptor (TLR) 4 with nasal interleukins in allergic rhinitis patients.
Zhu X; Cong J; Yang B; Sun Y
Cytokine; 2020 Feb; 126():154880. PubMed ID: 31739216
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures.
Maroso M; Balosso S; Ravizza T; Liu J; Aronica E; Iyer AM; Rossetti C; Molteni M; Casalgrandi M; Manfredi AA; Bianchi ME; Vezzani A
Nat Med; 2010 Apr; 16(4):413-9. PubMed ID: 20348922
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of HMGB1-TLR4 inflammatory pathway in focal cortical dysplasia type II.
Zhang Z; Liu Q; Liu M; Wang H; Dong Y; Ji T; Liu X; Jiang Y; Cai L; Wu Y
J Neuroinflammation; 2018 Jan; 15(1):27. PubMed ID: 29382328
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential of an anti-high mobility group box-1 monoclonal antibody in epilepsy.
Zhao J; Wang Y; Xu C; Liu K; Wang Y; Chen L; Wu X; Gao F; Guo Y; Zhu J; Wang S; Nishibori M; Chen Z
Brain Behav Immun; 2017 Aug; 64():308-319. PubMed ID: 28167116
[TBL] [Abstract][Full Text] [Related]
10. High-mobility group box 1 as a predictive biomarker for drug-resistant epilepsy: A proof-of-concept study.
Walker LE; Sills GJ; Jorgensen A; Alapirtti T; Peltola J; Brodie MJ; Marson AG; Vezzani A; Pirmohamed M
Epilepsia; 2022 Jan; 63(1):e1-e6. PubMed ID: 34747496
[TBL] [Abstract][Full Text] [Related]
11. HMGB1 Contributes to the Expression of P-Glycoprotein in Mouse Epileptic Brain through Toll-Like Receptor 4 and Receptor for Advanced Glycation End Products.
Chen Y; Huang XJ; Yu N; Xie Y; Zhang K; Wen F; Liu H; Di Q
PLoS One; 2015; 10(10):e0140918. PubMed ID: 26485677
[TBL] [Abstract][Full Text] [Related]
12. A Systematic Review of the Predictive and Diagnostic Uses of Neuroinflammation Biomarkers for Epileptogenesis.
Aguilar-Castillo MJ; Cabezudo-García P; García-Martín G; Lopez-Moreno Y; Estivill-Torrús G; Ciano-Petersen NL; Oliver-Martos B; Narváez-Pelaez M; Serrano-Castro PJ
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928193
[TBL] [Abstract][Full Text] [Related]
13. Expression of HMGB1 and TLR4 in neuropsychiatric systemic lupus erythematosus patients with seizure disorders.
Huang Q; Shen S; Qu H; Huang Y; Wu D; Jiang H; Yuan C
Ann Transl Med; 2020 Jan; 8(1):9. PubMed ID: 32055600
[TBL] [Abstract][Full Text] [Related]
14. Molecular isoforms of high-mobility group box 1 are mechanistic biomarkers for epilepsy.
Walker LE; Frigerio F; Ravizza T; Ricci E; Tse K; Jenkins RE; Sills GJ; Jorgensen A; Porcu L; Thippeswamy T; Alapirtti T; Peltola J; Brodie MJ; Park BK; Marson AG; Antoine DJ; Vezzani A; Pirmohamed M
J Clin Invest; 2017 Jun; 127(6):2118-2132. PubMed ID: 28504645
[TBL] [Abstract][Full Text] [Related]
15. Inflachromene attenuates seizure severity in mouse epilepsy models via inhibiting HMGB1 translocation.
Dai SJ; Shao YY; Zheng Y; Sun JY; Li ZS; Shi JY; Yan MQ; Qiu XY; Xu CL; Cho WS; Nishibori M; Yi S; Park SB; Wang Y; Chen Z
Acta Pharmacol Sin; 2023 Sep; 44(9):1737-1747. PubMed ID: 37076634
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of high mobility group box 1/toll-like receptor 4 in obese diabetic patients.
Liu S; Wang X; Kai Y; Tian C; Guo S; He L; Zhai D; Song X
Endocr J; 2022 Mar; 69(3):235-242. PubMed ID: 34657898
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic insights into high mobility group box-1 (HMGb1)-induced Toll-like receptor 4 (TLR4) dimer formation.
Sun S; He M; VanPatten S; Al-Abed Y
J Biomol Struct Dyn; 2019 Sep; 37(14):3721-3730. PubMed ID: 30238832
[TBL] [Abstract][Full Text] [Related]
18. TRIF contributes to epileptogenesis in temporal lobe epilepsy during TLR4 activation.
Wang FX; Yang XL; Ma YS; Wei YJ; Yang MH; Chen X; Chen B; He Q; Yang QW; Yang H; Liu SY
Brain Behav Immun; 2018 Jan; 67():65-76. PubMed ID: 28867282
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor 4 signaling: A common pathway for interactions between prooxidants and extracellular disulfide high mobility group box 1 (HMGB1) protein-coupled activation.
Zhang Y; Karki R; Igwe OJ
Biochem Pharmacol; 2015 Nov; 98(1):132-43. PubMed ID: 26367307
[TBL] [Abstract][Full Text] [Related]
20. High-mobility group box-1-Toll-Like receptor 4 axis mediates the recruitment of endothelial progenitor cells in alkali-induced corneal neovascularization.
Yang S; Yang TS; Wang F; Su SB
Int Immunopharmacol; 2015 Sep; 28(1):450-8. PubMed ID: 26202806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
